MAXIMUS, Inc. (MMS) Reaches $69.41 Formed H&S; Nwq Investment Management Company Raised Gilead Sciences (GILD) Holding By $1.82 Million

MAXIMUS, Inc. (NYSE:MMS) Logo

Nwq Investment Management Company Llc increased Gilead Sciences Inc (GILD) stake by 5.58% reported in 2017Q4 SEC filing. Nwq Investment Management Company Llc acquired 25,650 shares as Gilead Sciences Inc (GILD)’s stock rose 1.93%. The Nwq Investment Management Company Llc holds 484,957 shares with $34.74M value, up from 459,307 last quarter. Gilead Sciences Inc now has $97.39 billion valuation. The stock decreased 0.70% or $0.53 during the last trading session, reaching $74.69. About 4.24 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since April 17, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

MAXIMUS, Inc. (MMS) formed H&S with $63.16 target or 9.00% below today’s $69.41 share price. MAXIMUS, Inc. (MMS) has $4.53 billion valuation. The stock increased 1.85% or $1.26 during the last trading session, reaching $69.41. About 456,843 shares traded. MAXIMUS, Inc. (NYSE:MMS) has risen 5.08% since April 17, 2017 and is uptrending. It has underperformed by 6.47% the S&P500.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 126 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Buy” rating by Maxim Group on Tuesday, February 6. Oppenheimer initiated the stock with “Outperform” rating in Thursday, February 11 report. Piper Jaffray maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Wednesday, February 3. Piper Jaffray has “Overweight” rating and $114 target. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Monday, July 24 by J.P. Morgan. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by Maxim Group on Monday, August 28. Argus Research upgraded the stock to “Buy” rating in Thursday, August 31 report. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Monday, September 12 by Berenberg. The rating was maintained by Credit Suisse with “Outperform” on Wednesday, March 23. The rating was downgraded by Leerink Swann to “Mkt Perform” on Tuesday, September 27. The company was maintained on Tuesday, October 20 by Oppenheimer.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.23, from 1.03 in 2017Q3. It turned negative, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Tocqueville Asset Mngmt Ltd Partnership holds 0.07% or 86,717 shares. Ifc Fl reported 11,170 shares. Coldstream Cap Mgmt holds 0.05% in Gilead Sciences, Inc. (NASDAQ:GILD) or 6,927 shares. Newfocus Financial Grp Lc accumulated 6,509 shares. Wealthtrust Axiom Ltd stated it has 19,317 shares or 0.51% of all its holdings. Macquarie Grp holds 395,154 shares. Rafferty Asset Limited Liability Co has 19,812 shares. Moreover, Ifrah Financial Serv Inc has 0.14% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 5,484 shares. Cypress accumulated 0.61% or 41,178 shares. Shelter Mutual Insur owns 73,900 shares. Vident Invest Advisory Limited Liability Com reported 0.22% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Gofen And Glossberg Limited Liability Company Il holds 220,799 shares or 0.57% of its portfolio. Peak Asset Ltd Liability Com holds 73,791 shares or 1.93% of its portfolio. Florida-based St Johns Investment Management Ltd has invested 0.26% in Gilead Sciences, Inc. (NASDAQ:GILD). First Allied Advisory Svcs owns 101,559 shares.

Since January 2, 2018, it had 0 buys, and 17 sales for $39.51 million activity. Cogan John Francis also sold $472,065 worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Monday, March 12. 30,000 shares were sold by Alton Gregg H, worth $2.37M on Thursday, January 11. 60,000 shares were sold by WILSON GAYLE E, worth $4.68M on Friday, February 9. On Thursday, March 1 MARTIN JOHN C sold $3.93M worth of Gilead Sciences, Inc. (NASDAQ:GILD) or 50,000 shares. $401,566 worth of stock was sold by Washington Robin L on Wednesday, February 21. Meyers James R sold $8.02 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Tuesday, January 16.

Nwq Investment Management Company Llc decreased Hsbc Hldgs Plc (NYSE:HSBC) stake by 14,223 shares to 430,808 valued at $22.25M in 2017Q4. It also reduced Entegris Inc (NASDAQ:ENTG) stake by 229,473 shares and now owns 1.18M shares. Occidental Pete Corp Del (NYSE:OXY) was reduced too.

Among 8 analysts covering MAXIMUS (NYSE:MMS), 1 have Buy rating, 0 Sell and 7 Hold. Therefore 13% are positive. MAXIMUS has $87 highest and $59 lowest target. $67.80’s average target is -2.32% below currents $69.41 stock price. MAXIMUS had 36 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was maintained by Maxim Group with “Buy” on Thursday, February 4. The rating was downgraded by Maxim Group on Friday, May 5 to “Hold”. The stock has “Hold” rating by Canaccord Genuity on Friday, November 10. The rating was downgraded by Sidoti on Tuesday, November 15 to “Neutral”. The firm has “Hold” rating by Jefferies given on Monday, November 13. The company was initiated on Wednesday, September 16 by Canaccord Genuity. Jefferies maintained MAXIMUS, Inc. (NYSE:MMS) rating on Tuesday, May 31. Jefferies has “Buy” rating and $67 target. The stock of MAXIMUS, Inc. (NYSE:MMS) has “Hold” rating given on Wednesday, June 7 by Jefferies. The firm has “Buy” rating by Maxim Group given on Thursday, November 12. As per Thursday, September 28, the company rating was maintained by Jefferies.

Since December 15, 2017, it had 0 insider buys, and 4 insider sales for $2.53 million activity. $2.04 million worth of MAXIMUS, Inc. (NYSE:MMS) was sold by MONTONI RICHARD A. 1,000 MAXIMUS, Inc. (NYSE:MMS) shares with value of $66,550 were sold by BELIVEAU RUSSELL A. $232,200 worth of MAXIMUS, Inc. (NYSE:MMS) shares were sold by FRANCIS DAVID. The insider Andrekovich Mark sold $194,400.

Investors sentiment decreased to 1.1 in Q4 2017. Its down 0.29, from 1.39 in 2017Q3. It turned negative, as 22 investors sold MAXIMUS, Inc. shares while 101 reduced holdings. 46 funds opened positions while 89 raised stakes. 58.07 million shares or 1.27% more from 57.34 million shares in 2017Q3 were reported. Employees Retirement Systems Of Texas reported 31,000 shares. The Connecticut-based Paloma Prtn Mngmt has invested 0.01% in MAXIMUS, Inc. (NYSE:MMS). Us Comml Bank De reported 42,219 shares or 0.01% of all its holdings. Sei accumulated 19,768 shares. Citadel Advisors Lc reported 88,136 shares. Timessquare Capital Management Limited Com invested in 440,500 shares or 0.21% of the stock. Advantus Cap Mngmt stated it has 0.01% of its portfolio in MAXIMUS, Inc. (NYSE:MMS). Alta Cap Mgmt has invested 2.65% in MAXIMUS, Inc. (NYSE:MMS). Chatham Cap Group holds 0.62% or 31,650 shares in its portfolio. Robecosam Ag has invested 0.57% in MAXIMUS, Inc. (NYSE:MMS). Moreover, State Common Retirement Fund has 0.01% invested in MAXIMUS, Inc. (NYSE:MMS) for 74,010 shares. Brown Cap Mgmt Limited Com accumulated 7,664 shares or 0.01% of the stock. Makaira Limited Liability Corporation has invested 1.28% in MAXIMUS, Inc. (NYSE:MMS). The Washington-based Parametric Portfolio Assocs has invested 0.02% in MAXIMUS, Inc. (NYSE:MMS). Tradewinds Capital Ltd reported 196 shares.

MAXIMUS, Inc. (NYSE:MMS) Institutional Positions Chart